It is a pharma private limited company based in Patparganj, New Delhi, Delhi, India, established in 2017.
2017 | Patparganj, New Delhi, Delhi, India | ActiveStemmax Research And Therapeutics Private Limited, a active private limited company, was established on 07 February 2017 in Patparganj, New Delhi, Delhi, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U33309DL2017PTC312451. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Prabhu Chandra Mishra (Director), Umesh Chandra Mishra (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 69, Plot No. 35, Kallol Apartment I.P. Extn.,, Patparganj, New Delhi, Delhi, 110092.
U33309DL2017PTC312451
312451
07 February 2017
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Stemmax Research And Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabhu Chandra Mishra | Director | 07 Feb 2017 | Current |
| Umesh Chandra Mishra | Director | 07 Feb 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stemmax Research And Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 475.94% increase. The company also saw a substantial improvement in profitability, with a 229.58% increase in profit. The company's net worth Soared by an impressive increase of 101.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Stemmax Research And Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Stemmax Research And Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stemmax Research And Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stemmax Research And Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Stemmax Research And Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Stemmax Research And Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Prabhu Chandra Mishra was appointed as a Director was appointed as a Director on 07 Feb 2017 & has been associated with this company since 8 years 9 months . was completed.
The activity Umesh Chandra Mishra was appointed as a Director was appointed as a Director on 07 Feb 2017 & has been associated with this company since 8 years 9 months . was completed.
Progress on Stemmax Research And Therapeutics Private Limited was registered on 07 Feb 2017 with Roc Delhi & aged 8 years 9 months as per MCA records. was documented.
The CIN of Stemmax Research And Therapeutics Private Limited is U33309DL2017PTC312451.
Stemmax Research And Therapeutics Private Limited is headquartered at 69, Plot No. 35, Kallol Apartment I.P. Extn.,, Patparganj, New Delhi, Delhi, 110092.
Stemmax Research And Therapeutics Private Limited was incorporated on 07 February 2017.
The current directors of Stemmax Research And Therapeutics Private Limited are
The primary industry of Stemmax Research And Therapeutics Private Limited is Professional, Scientific And Technical.
Stemmax Research And Therapeutics Private Limited is unlisted.
The authorized capital of Stemmax Research And Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Stemmax Research And Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX